Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design

REFERENCES

• Banker G. S., Anderson N. R. Tablets. The Theory and practice of industrial pharmacy, L. Lachman, H. A. Liberman, J. L. Kanig. Varghese Publishing House: Mumbai, Mumbai 1987; 293–345
   Google Scholar
• Campbell D. B., Laveille R., Nathan C. The mode of action and clinical pharmacology of gliclazide: A Review. Diab. Res. Clin. Pract. 1991; 14: 21–36
   PubMed Web of Science ®Google Scholar
• Chowdary K. P. R., Kamalakara R. G. Sustained release of nifedipine from mucoadhesive tablets of its solid dispersions in HPMC and HPC. Indian Drugs 2002; 39(4)225–229
   Google Scholar
• Costa P., Sousa Lobo J. M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001; 13: 123–133
   PubMed Web of Science ®Google Scholar
• Delrat P., Paraire M., Jochemsen R. Complete bioavailability and lack of food effect on pharmacokinetics of gliclazide 30mg modified release in healthy volunteers. Biopharm. Drug Disp. 2002; 23: 151–57
   PubMed Web of Science ®Google Scholar
• Drouin P. Diamicron® MR once daily is effective and well tolerated in type 2 diabetes: A double-blind randomized multinational study. J. Diab. Comp. 2000; 14: 185–91
   Google Scholar
• Efentakis M., Buckton G. The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm. Dev. Tech. 2002; 7(1)69–77
   PubMed Web of Science ®Google Scholar
• Efentakis M., Koutlis A. Release of furosemide from multiple-unit and single-unit preparations containing different viscosity grades of sodium alginate. Pharm. Dev. Tech. 2001; 6(1)91–98
   PubMed Web of Science ®Google Scholar
• Einig H., Stieren B., Buehler V., Hollmann M. Sustained release tablet of a mixture of alginates and polyacrylates. United states patent-5230901, 1993
   Google Scholar
• European Medicines Agency (2006). Note for guidance on stability testing: Stability testing of new drug substances and products (CPMP/ICH/2736/99).
   Google Scholar
• Glowka F. K., Hermann T. W., Zabel M. Bioavailability of gliclazide from some formulation tablets. Int. J. Pharm. 1998; 172: 71–77
   Google Scholar
• Higuchi T. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963; 52: 1145–1149
   PubMed Web of Science ®Google Scholar
• Huang Y., Tsai Y., Lee S., Chang J., Wu P. Optimization of pH-dependent release of nicardipine hydrochloride extended release matrix tablets using response surface methodology. Int. J. Pharm. 2005; 289: 87–95
   PubMed Web of Science ®Google Scholar
• Kadhe G., Arasan R. E. Advances in drug delivery of oral hypoglycemic agents. Cur. Sci. 2002; 83(12)1539–1543
   Web of Science ®Google Scholar
• Korsmeyer R. W., Doelker G. E. P., Peppas N. A. Mechanisms of potassium chloride from compressed hydrophilic polymeric matrices: Effect of entrapped air. J. Pharm. Sci. 1983; 72: 1189–1191
   PubMed Web of Science ®Google Scholar
• Kuksal A., Tiwary A. K., Jain N. K., Jain S. Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS Pharm. Sci. Tech. 2006; 7(1), Article 1, DOI: 10.1208/pt070101.
   PubMed Web of Science ®Google Scholar
• Lee P. I. Novel zero order drug delivery via immobilized nonuniformed drug distribution in glassy hydrogels. J. Pharm. Sci. 1984; 73: 1344–1347
   PubMed Web of Science ®Google Scholar
• Lewis G. A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical experimental design. Marcel Dekker Inc, New York 1999
   Google Scholar
• Li S., Lin S., Chein Y. W., Daggy B. P., Mirchandani H. L. Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS Pharm. Sci. Tech. 2001; 2(1), article 1., http://www.aapspharmsci.org
   PubMedGoogle Scholar
• Li S., Lin S., Daggy B. P., Mirchandani H. L., Chein Y. W. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int. J. Pharm. 2003; 253: 13–22
   PubMed Web of Science ®Google Scholar
• Lieberman H. A., Rieger M. M., Banker G. S. Pharmaceutical dosage forms-Disperse systems. Marcel Dekker Inc, New York 1988
   Google Scholar
• Marshall K. Compression and consolidation of powdered solids. The theory and practice of industrial pharmacy, L. Lachman, H. A. Liberman, J. L. Kanig. Varghese Publishing House, Mumbai 1987; 67
   Google Scholar
• Mohamed S. R., Quadir M. A., Haider S. S. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled release drug delivery. J. Pharm. Pharmaceut. Sci. 2003; 6(2)274–291, www.ualberta.ca/~csps
   PubMedGoogle Scholar
• Mora P. C., Cirri M., Mura P. Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations. J. Pharm. Biomed. Anal. 2006; 42(1)3–10
   PubMed Web of Science ®Google Scholar
• Moustafine R. I., Kemenova V. A., Mooter G. V. Characteristics of interpolyelectrolyte complexes of Eudragit E 100 with sodium alginate. Int. J. Pharm. 2005; 294: 113–120
   PubMed Web of Science ®Google Scholar
• Moustafine R. I., Zaharov I. M., Kemenova V. A. Physicochemical characterization and drug release properties of eudragit EPO/eudragit L100-55 interpolyelectrolyte complexes. Eur. J. Pharm. Biopharm. 2006; 65(1)26–36
   PubMedGoogle Scholar
• Mura P., Furlanetto S., Cirri M., Maestrelli F., Marras A. M., Pinzauti S. Optimisation of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. J. Pharm. Biomed. Anal. 2005; 37: 65–71
   PubMed Web of Science ®Google Scholar
• Mutalik S., Udupa N. Glibenclamide transdermal patches: Physicochemical, pharmacodynamic and pharmacokinetic evaluations. J. Pharm. Sci. 2004; 93(6)1577–1593
   PubMed Web of Science ®Google Scholar
• Narendra C., Srinath M. S., Babu G. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS Pharm. Sci. Tech. 2006; 7(2), Article 34, DOI: 10.1208/pt070234.
   PubMed Web of Science ®Google Scholar
• Nath B. S., Venkatesh T., Hiremath D. Formulation and evaluation of sustained release dosage form of theophylline using a combined hydrophobic and hydrophilic matrix. Indian J. Pharm. Sci. 2000; 62(1)33–36
   Google Scholar
• Palmar K. J., Brogden R. N. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin dependent diabetes mellitus. Drugs 1993; 46: 92–125
   PubMed Web of Science ®Google Scholar
• Rao V. M., Engh K., Qiu Y. Design and pH-independent controlled release matrix tablets for acidic drugs. Int. J. Pharm. 2003; 252: 81–86
   PubMed Web of Science ®Google Scholar
• Sanchez-Lafuente C., Furlanetto S., Fernandez-Arevalo M., Alvarez-Fuentes J., Rabasco A. M., Faucci T., Pinzauti S., Mura P. Didanosine extended-release matrix tablets: Optimization of formulation variables using statistical experimental design. Int. J. Pharm. 2002; 237: 107–118
   PubMed Web of Science ®Google Scholar
• Singh B., Sukhwinder K. C., Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm. Sci. Tech. 2006; 7(1), Article 3, DOI: 10.1208/pt070103.
   Web of Science ®Google Scholar
• Skpoug J. W., Borin M. T., Fleishaker J. C., Cooper A. M. In vitro and in vivo evaluation of whole and half tablets of sustained release adinazolam mesylate. Pharm. Res. 1991; 8: 1482–1488
   PubMed Web of Science ®Google Scholar
• Streubel A., Siepmann J., Bodmeier R. Floating matrix tablets based on low-density foam powder: Effects pf formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 2003; 18: 37–45
   PubMed Web of Science ®Google Scholar
• Tadeusz W. H., Dobrucki R, Piechocki S., Resztak M., Reh R. Pharmaceutical availability of gliclazide from selected matrix formulation tablets. Med. Sci. Monit. 2005; 11(6)BR181–188
   PubMed Web of Science ®Google Scholar
• Tapia-Albarran M., Villafuerte-Robles L. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Drug Dev. Ind. Pharm. 2004; 30(8)901–908
   PubMed Web of Science ®Google Scholar
• Timothy M. E. D., Frank Daly, John P. W., Kenneth F. I., John P. B., Leon J. D. Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian aborigines with type-2 diabetes. J. Clin. Pharmacol. 2000; 49: 223–230
   Web of Science ®Google Scholar
• Tønnnesen H. H., Karlsen J. Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 2002; 28(6)621–630
   PubMed Web of Science ®Google Scholar